Skip to content

Clinical trials

Hepatitis B, Chronic trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Country / region: Australia Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20054
20074
20082
20091
20111
20123
20144
20152
20162
20173
20184
20205
20214
20222
20231
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Terminated6
Withdrawn2
Not yet recruiting2
Active, not recruiting2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences8
Hoffmann-La Roche7
Assembly Biosciences4
Bristol-Myers Squibb3
Enyo Pharma3
Arbutus Biopharma Corporation2
Brii Biosciences Limited2
GlaxoSmithKline2
Novartis2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic51
Hepatitis B18
Hepatitis7
DNA Virus Infections2
Hepatitis, Chronic2
Liver Diseases2
Blood-Borne Infections1
Chronic Disease1
Communicable Diseases1
Digestive System Diseases1

Trials

Showing 51 to 51 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.